API
< Back to all clusters
[BUSINESS] · Slovenia · 2 sources

started · updated

Krka approaches 500 million euros in profit

Pharmaceutical company Krka is reporting strong business momentum, with projections suggesting net profits could approach 500 million euros. In the first nine months of the year, the company saw an 8 percent increase in revenue and a 13 percent rise in net profit.

Operating profit grew by nearly 25 percent, driven by improved efficiency and stable costs of goods sold despite increased spending on research, development, and sales. Krka is currently exceeding its 2030 strategic targets, which aim for at least 5 percent annual sales growth and an EBITDA margin above 25 percent. The nine-month EBITDA margin reached 31.8 percent.

Entities

KRKA · Slovenia